Updates

GlaxoSmithKline Pharmaceuticals Limited GSK House, Dr. Annie Besant Road, Worli, Mumbai - 400 030 Tel No: +91 22 2495 9595 Fax No: +91 22 2495 9494 Web: www.gsk-india.com Email: askus@gsk.com 13th October 2026 BSE LIMITED THE NATIONAL STOCK EXCHANGE OF INDIA LIMITED Phiroze Jeejeebhoy Towers Exchange Plaza, 5th Floor, Plot No. C/1, G Block Dalal Street Bandra-Kurla Complex, Bandra (East) Mumbai - 400001 Mumbai - 400051 Dear Sir, Sub: Reconciliation of Share Capital Audit As required under Regulation 76 SEBI (Depositories and Participants) Regulations,2018, we enclose herewith a Share Capital Audit Report from Manish Ghia & Associates, Practicing Company Secretaries for the quarter ended 30th September 2026 regarding the reconciliation of the total admitted capital with both the Depositories and the total issued and listed capital. Kindly take the above intimation on your records. Thanking you, Yours faithfully For GlaxoSmithKline Pharmaceuticals Limited Ajay Nadkarni Vice President - Administration, Real Estate & Company Secretary CIN No. L24239MH1924PLC001151 RECONCILIATION OF SHARE CAPITAL AUDIT REPORT (Pursuant to Regulation 76 of the SEBI (Depositories and Participants) Regulations, 2018 r/w SEBI Circular dated 31.12.2002) 1 Report for quarter ended September 30, 2026 2 ISIN INE159A01016 3 Face Value Rs. 10/- each 4 Name of the Company GLAXOSMITHKLINE PHARMACEUTICALS LIMITED 5 Registered Office Address GSK House, Dr Annie Besant Road, Worli, Mumbai - 400030. 6 Correspondence Address Same as above 7 Telephone and Fax Nos. Ph.: 91- 022-24959595 8 Email Address in.investorquery@gsk.com 9 Name of the Stock Exchange where the company’s National Stock Exchange of India Limited; Securities are listed: BSE Limited Number of Shares % of Total Issued Capital 10 Issued Capital 16,94,15,420 100.00 11 Listed Capital (Exchange Wise) All 16,94,06,034 99.99 (as per company records) 12 Held in dematerialized form in CDSL 55,35,251 3.27 13 Held in dematerialized form in NSDL 16,28,10,133 96.10 14 Physical 10,60,650 0.62 15 Total No. of Shares (12+13+14) 16,94,06,034 99.99 16 Reasons for differences if any, between (10&11), (10&11), (10&15): (10&15), (11&15) 9,386 shares kept in abeyance 17 Certifying the details of changes in share capital during the quarter under consideration as per Table below: Particulars No. of Applied/ Listed on Whether Whether In principle shares Not Stock intimated to intimated to approval Applied exchanges CDSL NSDL pending for SE for listing (Specify s(specify names) names) 18 Register of Members is updated (Yes /No) Yes If not, updated up to which date - 19 Reference of previous quarter with regard to Nil excess dematerialized shares, if any 20 Has the Company resolved the matter mentioned in N.A. Point No.19 above, in the current quarter? If not reason why? 21 Mention the total no. of requests, if any, confirmed after 21 days and the total no. of requests pending beyond 21 days with the reasons for delay. Page 1 of 2 Total No. of demat requests No. of requests No. of shares Reason for delay Confirmed after 21 days. Nil Nil N.A. Pending for more than 21 days. Nil Nil N.A. 22 Name, Telephone & Fax No. of Compliance Mr. Ajay A. Nadkarni Officer of the company Vice President - Administration, Real Estate, Company Secretary & Compliance Officer Tel: - 022-24959595 Email: ajay.a.nadkarni@gsk.com 23 Name, Address, Telephone & Fax No., Regn No. of Mr. Mannish L. Ghia the Auditor Partner, M. No. FCS: 6252, C.P. No.3531 Manish Ghia & Associates Company Secretaries, 4, Old Chandan Niwas, 1st Floor, M. V. Road, Off. Andheri– Kurla Road, Behind Andheri Gymkhana, Andheri (East), Mumbai – 400 069. Tel No. 022 69025400/ 450 Email: mg@mgconsulting.in 24 Appointment of common agency for share KFin Technologies Limited registry work (if yes, name and address where CIN: L72400MH2017PLC444072 SEBI Registration No.: INR000000221 the operations are carried out) Selenium, Tower B, Plot No- 31 & 32, Financial District, Nanakramguda, Serilingampally, Hyderabad – 500032. Phone No.: 040 - 67161500/ 18003454001 Fax No.: 040 - 23001153 / 23420814 Email: einward.ris@kfintech.com Website: www.kfintech.com 25 Any other detail that the auditor may like to During the quarter, 60466 shares of the Company were provide, (e.g. BIFR Company, delisting from transferred to Investor Education Protection Fund Stock Exchange, company changed its name (IEPF) pursuant to Section 124(6) of the Companies etc.) Act, 2013. For Manish Ghia & Associates Company Secretaries MANNISH Digitally signed by MANNISH LALITCHA LALITCHANDRA NDRA GHIA Date: 2026.10.12 GHIA 17:24:06 +05'30' CS Mannish L. Ghia Partner Place: Mumbai M. No. FCS 6252, C.P. No. 3531 Date: October 12, 2026 Peer Review No.: - PR 6759/2025 UDIN: F006252H001828534 (FRN/Unique ID: P2006MH007100) Page 2 of 2